These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15690967)

  • 61. Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
    O'Brien EC; Holmes DN; Thomas LE; Fonarow GC; Allen LA; Gersh BJ; Kowey PR; Singer DE; Ezekowitz MD; Naccarelli GV; Ansell JE; Chan PS; Mahaffey KW; Go AS; Freeman JV; Reiffel JA; Peterson ED; Piccini JP; Hylek EM
    Circulation; 2018 Aug; 138(9):889-897. PubMed ID: 29678813
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study.
    Admassie E; Chalmers L; Bereznicki LR
    J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):329-336. PubMed ID: 29642709
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.
    Koudstaal PJ
    Cochrane Database Syst Rev; 2000; (2):CD000186. PubMed ID: 10796314
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Early initiation of new oral anticoagulants in acute stroke and TIA patients with nonvalvular atrial fibrillation.
    Shibazaki K; Kimura K; Aoki J; Saji N; Sakai K
    J Neurol Sci; 2013 Aug; 331(1-2):90-3. PubMed ID: 23743245
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.
    Shantsila E; Wolff A; Lip GY; Lane DA
    Br J Gen Pract; 2015 Jan; 65(630):e16-23. PubMed ID: 25548312
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cognitive impairment is not a predictor of failure to adhere to anticoagulation of stroke patients with atrial fibrillation.
    Horstmann S; Rizos T; Saribas M; Efthymiou E; Rauch G; Veltkamp R
    Cerebrovasc Dis; 2015; 39(5-6):325-31. PubMed ID: 25966900
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.
    Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE;
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E864-70. PubMed ID: 23765437
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial.
    Sambola A; Montoro JB; Del Blanco BG; Llavero N; Barrabés JA; Alfonso F; Bueno H; Cequier A; Serra A; Zueco J; Sabaté M; Rodríguez-Leor O; García-Dorado D
    Am Heart J; 2013 Oct; 166(4):669-75. PubMed ID: 24093846
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Rate of Clinical Outcomes in Atrial Fibrillation according to Antithrombotic Strategy: The COOL-AF Registry.
    Krittayaphong R; Winijkul A; Methavigul K; Sairat P; Investigators COOLF
    Cardiovasc Ther; 2022; 2022():5797257. PubMed ID: 35284003
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of Nonagenarians With Atrial Fibrillation: Insights From the Berlin Atrial Fibrillation (BAF) Registry.
    Wutzler A; von Ulmenstein S; Attanasio P; Huemer M; Parwani AS; Boldt LH; Haverkamp W
    J Am Med Dir Assoc; 2015 Nov; 16(11):969-72. PubMed ID: 26123257
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effectiveness of Adding Antiplatelets to Oral Anticoagulants in Patients with Acute Ischemic Stroke with Atrial Fibrillation and Concomitant Large Artery Steno-Occlusion.
    Kim JT; Lee JS; Kim BJ; Park JM; Kang K; Lee SJ; Kim JG; Cha JK; Kim DH; Park TH; Park SS; Lee KB; Lee J; Hong KS; Cho YJ; Park HK; Lee BC; Yu KH; Oh MS; Kim DE; Ryu WS; Choi JC; Kwon JH; Kim WJ; Shin DI; Sohn SI; Hong JH; Park MS; Choi KH; Cho KH; Lee J; Gorelick PB; Bae HJ
    Transl Stroke Res; 2020 Dec; 11(6):1322-1331. PubMed ID: 32472251
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Optimal use of antithrombotic agents in ischemic stroke with atrial fibrillation and large artery atherosclerosis.
    Kim TJ; Lee JS; Yoon JS; Oh MS; Kim JW; Park SH; Jung KH; Kim HY; Kwon JH; Choi HY; Kim HY; Eah KY; Han SW; Oh HG; Kim YJ; Shin BS; Kim CH; Kim CK; Park JM; Lee KB; Park TH; Lee J; Park MS; Choi JC; Kim C; Shin DI; Lee SJ; Kim DE; Cha JK; Kim EG; Yu KH; Hong KS; Lee YS; Lee JH; Sohn SI; Bae HJ; Lee YB; Lee JH; Rha JH; Lee BC; Chang DI; Ko SB; Yoon BW
    Int J Stroke; 2023 Aug; 18(7):812-820. PubMed ID: 36748980
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
    Diener HC; Aisenberg J; Ansell J; Atar D; Breithardt G; Eikelboom J; Ezekowitz MD; Granger CB; Halperin JL; Hohnloser SH; Hylek EM; Kirchhof P; Lane DA; Verheugt FWA; Veltkamp R; Lip GYH
    Eur Heart J; 2017 Mar; 38(12):860-868. PubMed ID: 26848150
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Persistence of secondary prevention medication and related factors for acute ischemic stroke and transient ischemic attack in China.
    Jiang Y; Yang X; Li Z; Pan Y; Wang Y; Wang Y; Ji R; Wang C
    Neurol Res; 2017 Jun; 39(6):492-497. PubMed ID: 28420316
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
    Dupree L; DeLosSantos M; Smotherman C
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):502-508. PubMed ID: 29806486
    [TBL] [Abstract][Full Text] [Related]  

  • 77. WITHDRAWN: Antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.
    Koudstaal PJ
    Cochrane Database Syst Rev; 1996 Apr; (1):CD000186. PubMed ID: 17636615
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Which risk factors are more associated with ischemic stroke than intracerebral hemorrhage in patients with atrial fibrillation?
    McGrath ER; Kapral MK; Fang J; Eikelboom JW; ó Conghaile A; Canavan M; O'Donnell MJ;
    Stroke; 2012 Aug; 43(8):2048-54. PubMed ID: 22618379
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation].
    Gandjour J; Zeindler J; Georgiadis D; Baumgartner RW
    Praxis (Bern 1994); 2005 Jan; 94(4):97-104. PubMed ID: 15732803
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
    Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
    Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.